Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates - 29/06/15
Doi : 10.1016/j.jpeds.2015.03.054
Robin K. Ohls, MD ⁎ 
Division of Neonatology, Department of Pediatrics, University of New Mexico, Albuquerque, New Mexico
∗Reprint requests: Robin K. Ohls, MD, MSC10 5590, University of New Mexico, Albuquerque, NM, USA 87131-0001.
Robert D. Christensen, MD
Divisions of Neonatology and Hematology Oncology, University of Utah School of Medicine, Salt Lake City, Utah
John A. Widness, MD
Stead Family Department of Pediatrics, University of Iowa Children's Hospital, Iowa City, Iowa
Sandra E. Juul, MD, PhD
Division of Neonatology, Department of Pediatrics, University of Washington, Seattle, Washington
Keyword : Epo, ESA, ROP
Le texte complet de cet article est disponible en PDF.
| Supported by the National Institutes of Health (NIH; R01 HD059856, U01 NS077953 [to R.O.], U01 NS077953, R01HD073128, U01NS077953 [to S.J.], P01 HL046925, U01 NS077953 [to J.W.]), and Intermountain Healthcare Medical Foundation (to R.C.). J.W. is a paid consultant to HemoGenix. The other authors declare no conflicts of interest. |
© 2015
Elsevier Inc. Tous droits réservés.
Vol 167 - N° 1
P. 10-12 - juillet 2015 Retour au numéro
Article précédent
- Prevention of Cerebral Palsy: Which Infants Will Benefit from Therapeutic Hypothermia?
- Marie T. Berg
- Developing Indigenous Therapeutic Calcium Supplementation for Treating Nutritional Rickets
- Aashima G. Dabas, Rajesh Khadgawat
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?